» Articles » PMID: 38084251

Evaluation of a New Molecular Test for the Detection of SARS-CoV-2 Nucleic Acid in Salivary Samples

Overview
Journal J Med Biochem
Specialty Biochemistry
Date 2023 Dec 12
PMID 38084251
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Molecular testing is considered the gold standard for the detection of SARS-CoV-2. This study aimed to compare the performance of the P742H SARS-CoV-2 Nucleic Acid Multiplex Detection Kit in salivary samples, with respect to the 732HF Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit and the TaqPath COVID-19 CEIVD RT-PCR Kit, used at University-Hospital of Padova, Italy.

Methods: One hundred twenty-four salivary samples selfcollected by healthcare workers (HCW) during the screening program at University-Hospital of Padova, Italy, from Oct to Nov 2022, were included in the study. RNA extraction was performed by Viral DNA and RNA Extraction Kit (Technogenetics, Lodi, Italy) and amplification by P742H and 732HF (Technogenetics, Lodi, Italy). RNA was extracted using MagNa Pure 96 DNA and Viral NA Small Volume Kit (Roche, Switzerland) for TaqPath analysis (Thermo Fisher Scientific, USA).

References
1.
Basso D, Aita A, Navaglia F, Mason P, Moz S, Pinato A . The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave. BMC Med. 2022; 20(1):96. PMC: 8865498. DOI: 10.1186/s12916-022-02297-1. View

2.
Banko A, Petrovic G, Miljanovic D, Loncar A, Vukcevic M, Despot D . Comparison and Sensitivity Evaluation of Three Different Commercial Real-Time Quantitative PCR Kits for SARS-CoV-2 Detection. Viruses. 2021; 13(7). PMC: 8309997. DOI: 10.3390/v13071321. View

3.
Yokota I, Shane P, Okada K, Unoki Y, Yang Y, Inao T . Mass Screening of Asymptomatic Persons for Severe Acute Respiratory Syndrome Coronavirus 2 Using Saliva. Clin Infect Dis. 2020; 73(3):e559-e565. PMC: 7543374. DOI: 10.1093/cid/ciaa1388. View

4.
You H, Lin M, Lee C . Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19. Biomed J. 2021; 44(1):101-104. PMC: 7771907. DOI: 10.1016/j.bj.2020.12.007. View

5.
Lippi G, Henry B . Possible drawbacks of relying only on molecular testing for diagnosing SARS-CoV-2 infections. Public Health. 2021; 205:e2. PMC: 8491921. DOI: 10.1016/j.puhe.2021.09.035. View